Evidence map›Paper›PMID 32030200›Full record

GuidelineStroke and vascular neurology2019

Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of spontaneous subarachnoid haemorrhage.

Yi Dong, Zhen-Ni Guo, Qi Li, Wei Ni, Hongqiu Gu, Yu-Xiang Gu, Qiang Dong, Chinese Stroke Association Stroke Council Guideline Writing Committee

Open access · goldAbstract readPractice GuidelineReview
In one paragraph

Guideline in Stroke and vascular neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Yi DongDepartment of Neurology, Huashan Hospital,Fudan University, Shanghai, China.ORCID 0000-0001-6630-112X
Zhen-Ni GuoDepartment of Neurology, The First Hospital of Jilin University, Jilin, China.
Qi LiDepartment of Neurology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Wei NiNeurosurgery, Fudan University Huashan Hospital Department of Neurosurgery, Shanghai, China.
Hongqiu GuChina National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.ORCID 0000-0003-1608-1856
Yu-Xiang Gu *Neurosurgery, Fudan University Huashan Hospital Department of Neurosurgery, Shanghai, China.
Qiang Dong *Department of Neurology, Huashan Hospital,Fudan University, Shanghai, China.ORCID 0000-0002-3874-0130
Chinese Stroke Association Stroke Council Guideline Writing Committee
Fudan University · CNCapital Medical University · CNJilin University · CNThe Affiliated Yongchuan Hospital of Chongqing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: Spontaneous subarachnoid haemorrhage (SAH) caused by ruptured cerebral aneurysm is a severe subtype of haemorrhagic stroke. Although the incidence of SAH is relatively low among all cerebrovascular diseases, the mortality is the highest. The critical management of SAH is challenging. We provide this evidence-based guideline to present current and comprehensive recommendations for the diagnosis and treatment of non-trauma SAH. Methods: A formal literature search of MEDLINE (1 January 1990-30 June 2019) was performed. Data were synthesised with the use of evidence tables. Writing group members met by teleconference to discuss data-derived recommendations. The Chinese Stroke Association's levels of evidence grading algorithm was used to grade each recommendation. The guideline draft was reviewed by Chinese Stroke Association's Stroke Fellow Committees. It is intended that this guideline be fully updated every 3 years. Results: Evidence-based guidelines are presented for the care of patients presenting with non-trauma SAH. The focus of the guideline was subdivided into transfer and systems of care, diagnosis flowchart, aetiology and differentiation, prevention of rebleeding, surgical and endovascular repair of ruptured aneurysms, management of vasospasm and delayed cerebral ischaemia, management of hydrocephalus, management of seizures and management of medical complications. Conclusions: The guideline offers a framework for SAH management. Early professional and aggressive care of SAH might help dramatically.

Indexed as

ChinaConsensusEarly DiagnosisEvidence-Based MedicineHumansNeurologyRisk FactorsSeverity of Illness IndexSubarachnoid HemorrhageTime FactorsTime-to-TreatmentTreatment Outcomestrokesubarachnoid

Identifiers

PMID32030200
PMCPMC6979866
OpenAlexW2995008994

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.